BioSpace News Archive

Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announced that Larry Brown, Sc.D., Chief Scientific Officer, will present on its retinal and optic nerve disease clinical program at the Glaucoma Research Foundation’s 9th Annual Glaucoma 360 Meeting on Friday, February 7, 2020 at 3:29 PM P.T. (6:29 PM E.T.) in San Francisco, CA.

New products offer increased flexibility and efficiency for low- to high-volume molecular testing laboratories

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that Nestlé Health Science will make an additional equity investment in Aimmune of $200 million, bringing Nestlé’s total investment in Aimmune to date to $473 million.

Diomics Corporation, a leader in forensic, diagnostic, and therapeutic science since 2009, today announced that it has developed intellectual property and patents related to the identification of airborne pathogens.

TumorGenesis, Inc. a subsidiary of Predictive Oncology, Inc. (NASDAQ: POAI) has selected US Biological Corporation of Salem, Massachusetts as the manufacturer and distributor of its innovative culture media for growing ovarian tumor cells.

Company positioned for continued growth in health care, life sciences, human resources/employer, and legal conferences.

Feb. 5, 2020 14:00 UTC Yasmeen Rahimi, PhD, to speak on NASH and other new Liver Treatments NEWPORT BEACH, Calif.--( BUSINESS WIRE )-- ROTH Capital Partners (“ROTH”), a full service investment bank focused on advising and financing growth companies, is pleased to announce its participation as a sponsor and panelist at the BIO CEO & Investor Conference on February 10-11, 2020 in New York City. Yasmeen Rahimi, PhD – Managing Director, Senior Research Analyst, and Co-

Smooth Transition Ensured as VP of Clinical Operations Takes Helm

Business Activity Index at 60.9%; New Orders Index at 56.2%; Employment Index at 53.1%

Walgreens Boots Alliance, Inc. announced the appointment of Richard Ashworth as President of Walgreens.